Showing results (2001-2010 of 2,202) with videos related to

Sort By:
Pageof 221
Iscience|September 4, 2023
Hematopoietic stem and progenitor cells confer cross-protective trained immunity in mouse modelsBailee N Kain, Brandon T Tran, Pamela N Luna, et al.
Annals of the American Thoracic Society|January 28, 2014
Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial diseaseKenneth N Olivier, Pamela A Shaw, Tanya S Glaser, et al.
Public Health Nutrition|June 25, 2016
Biomarker-predicted sugars intake compared with self-reported measures in US Hispanics/Latinos: results from the HCHS/SOL SOLNAS studyJ M Beasley, M Jung, N Tasevska, et al.
Iscience|April 9, 2025
Erratum: Hematopoietic stem and progenitor cells confer cross-protective trained immunity in mouse modelsBailee N Kain, Brandon T Tran, Pamela N Luna, et al.
Vaccine|August 21, 2025
Design and preclinical assessment of mRNA-1345 prefusion F glycoprotein-encoding mRNA vaccine for respiratory syncytial virusChristine A Shaw, Guillaume B E Stewart-Jones, Patricia Jorquera, et al.
JAMA|May 7, 2025
Immunogenicity and Safety of Influenza and COVID-19 Multicomponent Vaccine in Adults ≥50 Years: A Randomized Clinical TrialAmanda K Rudman Spergel, Iris Wu, Weiping Deng, et al.
American Journal of Medical Genetics. Part A|July 30, 2008
Identification of chromosome abnormalities in subtelomeric regions by microarray analysis: a study of 5,380 casesLina Shao, Chad A Shaw, Xin-Yan Lu, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 10, 2007
Circadian rhythms in myocardial metabolism and contractile function: influence of workload and oleateDavid J Durgan, Michael W S Moore, Ngan P Ha, et al.
Journal of Medicinal Chemistry|September 11, 1998
ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivoA D Gribble, R J Ife, A Shaw, et al.
Scientific Reports|June 4, 2024
An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapyConstantinos Demetriou, Naila Abid, Michael Butterworth, et al.
Pageof 221